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C e rebral embolism from cardiac source (CECS) i s
c o n s i d e red the cause of 15 to 45% of all strokes, a n d
many studies suggest that it is more prevalent in p a-
tients younger than 45 years old1 - 3. The absence
of qualitatively valid criteria for the clinical diagno-
sis of CECS, and the frequent coexistence of a po-
tential cardiac source of emboli and cerebral ath-
e ro s c l e rosis, make the diagnosis presumptive in
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ABSTRACT - Cerebral embolism from cardiac source is an important cause of stroke, specially in patients
younger than 45 years old. Objective: To describe the transesophageal echocardiography (TEE) findings
in young and non-young stroke patients without any prior evidence of cardiac source for cerebral embolism.
Method: Transversal study: 523 patients (267 men and 256 women) with ischemic stroke, without any evi-
dence of cardiac abnorm a l i t y, underwent to TEE. Results: Ten percent were aged 45 years; or less. Left ven-
tricle hypert ro p h y, left atrial enlargement, spontaneous contrast in aorta, interatrial septum aneury s m ,
mitral and aortic valve calcification, aortic valve regurgitation, and atherosclerotic plaques in aorta were
significantly more frequent in patients aged more than 45 years; 2.8% of non-young patients had thro m-
bus in left heart . Conclusion: TEE is widely used to diagnose cardiac source of cerebral embolism in young
patients, but it seems to be as useful for older ones, in whom cerebral embolism risk is undere s t i m a t e d ;
atherogenic and cardioembolic causes may actually coexist, and both should be treated. 
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E c o c a rdiograma transesofágico revela fonte cardíaca de embolia cerebral em pacientes com
AVC e mais que 45 anos
RESUMO - Embolia cerebral de fonte cardíaca é frequentemente relacionada a acidente vascular cerebral
( AVC) em jovem. Objetivo: D e s c rever achados ecocardiográficos em jovens e não jovens com AVC isquêmi-
co, sem suspeita de fonte card í a c a . Método: Estudo transversal; 523 pacientes (267 homens e 256 mulhe-
res) com AVC isquêmico sem evidência de fonte cardíaca submeteram-se ao ecocardiograma transesofágico
( E C O T E ) . Resultados: 10% dos pacientes tinha 45 anos; ou menos. Hipert rofia do ventrículo esquerd o ,
aumento do átrio esquerdo, contraste espontâneo na aorta, aneurisma do septo interatrial, calcificação
da válvula mitral e aórtica, insuficiência aórtica e placas de ateroma na aorta foram significantemente mais
frequentes nos pacientes com mais que 45 anos; 2.8% dos não-jovens apresentaram trombo nas câmaras
esquerdas. Conclusão: ECOTE é amplamente sugerido na investigação de embolia em pacientes jovens,
porém parece ser tão importante também no grupo de pacientes mais velhos, nos quais o risco de embo-
lia cerebral é subestimado; etiologia cardioembólica e aterosclerótica coexistem, e ambas devem ser identi-
ficadas e tratadas para melhor prognóstico.
PALAVRAS-CHAVE: acidente vascular cerebral, embolia cardíaca, ecocardiograma transesofágico.
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many situations. There is neither consensus nor
guidelines for diagnosis of CECS. About one third
of all stroke patients have some clinical evidence
of potential cardiac source of embolism by physi-
cal examination, chest roentgenogram or electro-
c a rd i o g r a m2. The classical cardiac conditions asso-
ciated with CECS are nonvalvular atrial fibrillation,
acute myocardial infarction, ventricular aneury s m ,
rheumatic heart disease, and prosthetic valves, and
some studies have correlated specific entities to l e s s
common potential cardiac source of cerebral em-
bolism: mitral valve prolapse, mitral annulus calcifi-
cation, nonbacterial thrombotic endocarditis, cal-
cified aortic valve stenosis, myxoma, paradoxical e m-
bolism and congenital heart disease, nonischemic
dilated card i o m y o p a t h y, and infective endocar-
d i t i s1. Aging produces major cardiovascular chan-
ges, including decreased elasticity and compliance
of the aorta and other arteries, that leads to high-
er systolic arterial pre s s u re and increased i m p e d a n-
ce to left ventricle ejection, and subsequent left v e n-
tricle hypert ro p h y. Heart valves thicken and calcifi-
cation results at the basis of aortic valve and mitral
annulus causing valve dysfunction. Aortic valve c a l-
cification is associated with athero s c l e rotic disea s e ,
specially coronary artery disease. Various types of
a rrhythmia are associated with cell d e g e n e r a t i o n ,
and occur preferentially in the elderly4. 
The transesophageal echocardiography (TEE)
was first used in 1971, and has been very useful in
the diagnosis of many cardiac abnormalities, some
of them associated to unsuspected ethiology for
s t roke, as follows: patent foramen ovale, atrial c o m-
munication, atrial septal aneurysm, aortic athero-
matous plaques, echocardiographic spontaneous
contrast, mitral valve strands, intracardiac thro m-
bus specially in left appendage5 - 7. The TEE has be-
en more widely used since the eighties when tech-
nical improvements mostly re g a rding transducers,
and topic anesthetic pro c e d u res were achieved3 , 8.
It is well known the superiority of TEE compared t o
transthoracic echocardiography to detect the abo-
ve mentioned abnorm a l i t i e s3 , 8 - 1 2, but even so, it is
not widely used in the stroke investigation13.
Some algorithms for cardiac evaluation, until l a s t
decade, included TEE for young stroke patients, a n d
for older only if there was some evidence of card i a c
d i s e a s e9 , 1 4 - 1 7. A recent guideline recommend echo-
c a rdiography for young stroke patients and for
older patients (typically more than 45 years) only
with neurological events without evidence of cere-
brovascular disease or other obvious cause18.
The objective of this study was to describe the
TEE findings in young and non-young stroke pa-
tients without any prior evidence of cardiac sourc e
for cerebral embolism. Our hypothesis is that we are
u n d e restimating cerebral embolism risk in an older
population and there f o re it would be useful to sub-
mit every patient with acute stroke to TEE in ord e r
to diagnose unsuspected sources of embolism. 
METHOD
Patients and design – Transversal study with consecu-
tive inclusion of 523 adult patients between November
1998 and March 2004. Patients were admitted to the
Division of Neurological Emergencies of São Paulo Hos-
pital at Federal University of São Paulo, and were en-
rolled if they fulfilled the entry criteria, and signed the
consent form. The diagnosis of ischemic stroke were per-
f o rmed by neurologists following a standard pro t o c o l
including clinical examination and brain CT scan. The se-
lected patients underwent TEE up to 15 days after stro k e .
Exclusion criteria – Patients bearing any clinical sus-
picion of cardioembolism like atrial fibrillation, re c e n t
myocardial infarction (in the last 6 months), prosthetic
c a rdiac valves, severe impairment of cardiac function,
f o rmal contraindication for TEE, critical care re q u i re d
or those hospitalized for more than 14 days were exclud-
ed from the study.
G roup assignment – Based on current criteria patients
aged 45 or less were considered young, and those aged
m o re than 45 years were considered non-young1 9. To
analyze clinical data we split our sample into male and
female groups because known epidemiological diff e re n-
ces among them.
T E E – Multplane transesophageal echocard i o g r a p h y
with a 5mHz transesophageal probe (Vingmed echocar-
diography System V) were perf o rmed to the selected
patients. Images were recorded on videotape for later
review by two observers. TEE examinations were per-
f o rmed after administration of topical anesthesia with
an aerosolized 10% solution of lydocaine and intrave-
nous sedation with midazolan (1.5mg/ml) and meperidi-
ne (50mg/ml). Contrast studies were perf o rmed thro u g h
rapid injection of microbubble solution (6ml of isoton-
ic saline 0.9%, 4ml of glucosis 50%, and 1ml of air) in
the peripheral vein at rest, during coughing, and Va l s a l-
va maneuver. A comprehensive TEE examination was
p e rf o rmed with standardized scan planes. The follow-
ing abnormalities were evaluated: left atrium enlarg e-
ment, presence of masses, thrombi, or spontaneous con-
trast either inside the atrium or at the atrial appendage
or left ventricle, interatrial septum aneurysm; patent f o r a-
men ovale, or any interatrial septal communication; fi-
brosis, mitral valve strands, calcifications, myxomatous
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degeneration, significant stenosis, or re g u rgitation of
the mitral or aortic valve; enlargement, hypert ro p h y,
left ventricle segmental or global dysfunction; and also
atherosclerotic plaques or thrombi in the thoracic aor-
ta. Patent foramen ovale was diagnosed if more than
t h ree microbubbles were detected in the left atrium wi-
thin 5 cardiac cycles, following the opacification in the
right atrium. Interatrial septal aneurysm was diagnosed
when excessive expansion was observed. Spontaneous
echo contrast was characterized by smooth echoes with
c i rcular or spiral movement inside cardiac chambers. Mi-
tral valve strands were defined as a thin mobile filamen-
tous projections attached to the atrial surface of mitral
leaflets or subvalvar apparatus. The left atrium was con-
s i d e red enlarged when it was >40mm. The left ventri-
cle was considered enlarged when diastolic diameter
was >50mm and hypert rophic when diastolic thickness
was ≥12mm; athero s c l e rotic plaques in the ascending
a o rta, aortic arch, and descending aorta had their max-
imum thickness measured and were classified into 2
groups: those <4mm and those ≥4mm. 
Statistical analysis – Pro p o rtions and 95% confidence
i n t e rval were computed for echocardiographic findings.
Q u i - s q u a re tests were perf o rmed to compare the pro p o r-
tions of each group. A p value < 0.05 was considere d
significant. Calculations were perf o rmed with SPSS 12
(SPSS Inc., U.S.A.) statistical package.
The sponsor played no role in elaboration and con-
duction of this study.
RESULTS
T h e re were 523 patients included in the study
(267 men and 256 women); the ages ranged fro m
26 to 92 years (mean = 62.8; SD=12.47). Fifty-four
patients (10.3%) were aged 45 years or less (23 man
and 31 women) and 469 patients (89.7%) were aged
m o re than 45 years (244 men and 225 women).
No complications occurred during the echocar-
diography exam. One patient could not be submit-
ted to TEE because of esophagitis diagnosed dur-
ing the procedure. 
The women of non-young group presented a
higher pro p o rtion of hypertension and diabetes,
and lower pro p o rtion of cigarette smoking. The
men of non-young group had lower pro p o rt i o n
of cigarette smoking (Table 1).
Left ventricle hypert ro p h y, left atrial enlarg e-
ment, spontaneous contrast in aorta, interatrial
septum aneurysm, mitral valve calcification, aort i c
valve calcification, aortic valve re g u rgitation, and
a t h e ro s c l e rotic plaques in aorta were more fre-
quent in patients aged more than 45 years. Echo-
c a rdiographic findings are presented in Table 2.
Neither mass in left atrium or ventricle nor strands
in mitral valve were found. 
Four patients had intermittent atrial fibrilla-
tion not present during emergency management,
all of them were aged more than 45 years old. F o u r
patients presented aortic aneurysms with signs of
dissection (43 years old woman, 46 years old wo-
man, 59 years old woman, and 58 years old man).
In 1 patient of young group, who had aortic aneu-
rysm dissection and also thrombus, and in 17 pa-
tients of non-young group (atrial fibrillation, aor-
tic aneurysm dissection, mitral stenosis, aortic ste-
nosis, or thrombus) the treatment change was m a n-
d a t o ry, and was perf o rmed immediately after TEE. 
Six TEE were considered normal (14.3%) in the
g roup of young patients, and 5 (1.4%) amongst
older patients (p<0.0001).
DISCUSSION
The pro p o rtion of young patients with stroke i n
the present study (10.8%) was similar to that pre-
viously re p o rted in Brazil (10.6% of cerebral in-
f a rc t )2 0, and in other countries2 1, showing that stro-
ke is not rare in young people. Considering that c a r-
dioembolism is an important ethiology of stro k e
in young people (12 to 35% of the cases)2 , 1 9 , 2 2 , 2 3,
and that patients with any suspected cardiac sour-
ce of embolism were excluded from our study, the
Table 1. Atherosclerotic risk factors of male and female stroke patients distributed by ages.
Women (n=256) Men (n=267)
≤ 45 years >45 years p ≤ 45 years >45 years p
(n=31) (n=225) (n=23) (n=224)
Hypertension 18 192 0.0002 14 189 0.0748
Diabetes mellitus 4 69 0.0400 2 60 0.0844
Previous stroke 5 53 0.3544 5 60 0.7607
Coronary disease 2 26 0.3933 4 42 0.9827
Cigarette smoking 20 49 <0.0001 16 107 0.0180
Qui-square test.
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actual proportion is likely to be even greater. Be-
cause of the low prevalence of atherosclesosis in
the young, the cardiac conditions are more freq u e n t-
ly related to the ethiology of stroke2,21,24. 
Left ventricular hypert ro p h y, left atrial enlarg e-
ment, left ventricle enlargement, spontaneous con-
trast in aorta, mitral valve calcification, aortic valve
calcification, aortic valve re g u rgitation, and athero-
s c l e rotic plaques in aorta are related to aging, and
w e re more prevalent in the older group as expect-
ed. PFO occurred in the older group in same pro p o r-
tion as younger group. PFO and atrial septal aneu-
rysm are typically related to cryptogenic stro k e2 5. 
Atrial fibrillation and myocardial infarction are
m o re prevalent in older patients, and are conside-
red main sources of emboli1. However, in this study
patients with some cardiac source of embolism
w e re previously excluded, so the TEE findings were
unexpected. Cabral et al. studied a similar popu-
lation, without cardiac source of embolism, and
found also more abnormalities in older gro u p2 6.
We have previously re p o rted that 16% of patients
had their treatments changed after TEE, leading
to significant clinical impact27. 
In current guideline for clinical application of
e c h o c a rd i o g r a p h y, it is recommended for younger
patients, typically less than 45 years, with cere b ro-
vascular events and for older patients, typically
m o re than 45 years, with neurological events with-
out evidence of cere b rovascular disease or other
obvious cause. As aging is frequently related to
obvious cause of ischemic stroke, considered athe-
Table 2. Echocardiography findings in patients younger and older than 45 years.
≤ 45 years (N=54) > 45 years (N=469)
Echocardiographic N proportion 95%Confidence N proportion 95%Confidence p
findings interval interval
Left ventricle hypertrophy 8 0.1481 0.0662 - 0.2712 200 0.4264 0.3812 - 0.4726 0.0001
Left atrium enlargement 3 0.0556 0.0116 - 0.1539 128 0.2729 0.2331 - 0.3157 0.0005
Left ventricle enlargement 6 0.1111 0.0419 - 0.2263 101 0.2154 0.1790 - 0.2554 0.0721
Spontaneous contrast 4 0.0741 0.0206 - 0.1789 77 0.1642 0.1318 - 0.2009 0.0831
in left atrium
Spontaneous contrast 0 0 21 0.0448 0.0279 - 0.0676 0.1125
in left ventricle
Spontaneous contrast 0 0 45 0.0959 0.0708 - 0.1263 0.0173
in aorta
Thrombus in left atrium 0 0 5 0.0107 0.0035 - 0.0247 0.4458
Thrombus in left ventricle 0 0 3 0.0064 0.0013 - 0.0186 0.5556
Thrombus in aorta 1 0.0185 0.0005 - 0.0989 5 0.0107 0.0035 - 0.0247 0.6076
Interatrial septum aneurysm 0 0 38 0.0810 0.0580 - 0.1095 0.0298
Patent foramen ovale 15 0.2778 0.1646 - 0.4164 111 0.2367 0.1989 - 0.2778 0.5036
Mitral valve calcification 0 0 91 0.1940 0.1592 - 0.2328 0.0004
Aortic valve calcification 1 0.0185 0.0005 - 0.0989 155 0.3305 0.2880 - 0.3751 <0.0001
Mitral valve regurgitation 34 0.6296 0.4874 - 0.7571 349 0.7441 0.7021 - 0.7830 0.0719
Aortic valve regurgitation 7 0.1296 0.0537 - 0.2490 193 0.4115 0.3666 - 0.4576 0.0001
Atherosclerotic plaque 12 0.2222 0.1204 - 0.3560 239 0.5096 0.4633 - 0.5557 0.0001
<4mm in aorta
Atherosclerotic plaque 2 0.0370 0.0045 - 0.1275 125 0.2665 0.2270 - 0.3090 0.0002
>4mm in aorta
Myxomatous valve 0 0 4 0.0085 0.0023 - 0.0217 0.4957
degeneration
Mitral stenosis 1 0.0185 0.0005 - 0.0989 3 0.0064 0.0013 - 0.0186 0.3329
0Aortic stenosis 0 0 3 0.0064 0.0013 - 0.0186 0.5556
Qui-square test
Arq Neuropsiquiatr 2005;63(4) 945
ro t h rombotic event, other etiologies are not syste-
matically investigated1 4. Last Brazilian echocard i o-
graphy guideline also states as class I re c o m m e n d a-
tion echocardiography for young patients (<45
years) with acute stroke, for patients older than
45 years without evidence of cere b rovascular disea-
se, and for stroke with preexisting cere b ro v a s c u-
lar disease with suspicion of embolus; also makes
class II recommendations for echocardiography af-
ter acute neurological symptoms in patients with
p reexisting cere b rovascular disease, and for pa-
tients with stroke in whom echocardiography w o u l d
not interfere in diagnosis or management28. 
C l i n i c a l2 9, or review studies9 , 1 7 , 3 0 re c o m m e n d
e c h o c a rdiography with the same restrictions of
c u rrent guidelines, i.e., only for patients with s t ro k e
and atrial fibrillation, coro n a ry art e ry disease, and
other cardiac diseases. Few studies re c o m m e n d
e c h o c a rdiography for patients without clinical sus-
picion of cardiac source of embolism5.
In our study we found in the group of non-y o u n g
patients, 13 individuals (2.8%) with some thro m-
bus, 6 (1.3%) with mitral or aortic valve stenosis,
4 (0.9%) with thoracic aorta dissection, 4 (0.9%)
with intermittent atrial fibrillation. Those patients
demanded proper management, as well as some
patients with other TEE abnormalities needed spe-
cific care. In the group of young patients 54 TEE w e-
re perf o rmed and we found one case of thro m-
bus, while in the non-young group a change in
management was mandatory at each 21 TEE.  
TEE is widely used to diagnose cardiac sourc e
of cerebral embolism in young patients, but it se-
ems to be as useful for older ones, in whom athe-
rogenic and cardioembolic causes may actually c o e x-
ist. In these patients the ethiological diagnosis of
s t roke is even more difficult, and it might be mul-
tifactorial. Each cause should be promptly identi-
fied and treated, reducing recurrence. 
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